T/CACM 1232-2019 Active Group standards

T/CACM 1232-2019 Chinese medicine clinical diagnosis and treatment guidelines for internal medicine: True heart attack (post-PCI)

Publish Date: 2019-01-30 Implement Date: 2020-01-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CACM 1232-2019

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: Medicine

ICS Name: Comprehensive Pharmaceutical Science

Publish Date: 2019-01-30

Implement Date: 2020-01-01

Scope

Main technical content: This guideline follows the principles of diagnosis and treatment based on syndrome differentiation in traditional Chinese medicine, and summarizes the classification of syndromes and treatments, therapeutic methods, prescriptions, and preventive care for patients with acute myocardial infarction after PCI. It is applicable to patients aged 18 and above who still have residual risks such as angina pectoris (with slow blood flow and TIMI grade I-II) after blood vessel reconstruction after PCI for acute myocardial infarction (including STEMI and NSTEMI). This guideline is suitable for clinicians in related departments such as cardiology, emergency medicine, critical care medicine, and traditional Chinese medicine.